• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number UNK776
Device Problem Occlusion Within Device (1423)
Patient Problems Infarction, Cerebral (1771); Congestive Heart Failure (1783); Myocardial Infarction (1969); Reocclusion (1985)
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the complaint device was not received for analysis.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2018-03978.It was reported at an academic conference (b)(4), that in-stent restenosis, myocardial infarction, cerebral infarction, and heart failure occurred.The aim of this study was to investigate the initial clinical results of synergy relative to the non-bsc stent.Percutaneous coronary intervention was performed to 609 lesions from (b)(6) 2015 to (b)(6) 2016.513 lesions which were received synergy stents were subject to this study.The primary end point was in-stent restenosis at follow-up angiography.The secondary end point was the incidence of adverse events including acute myocardial infarction, heart failure and cerebral infarction.In-stent restenosis rate of synergy was significantly increased than that of the non-bsc stent.On (b)(4) method, the patency rate of synergy was significantly decreased compared with that of non-bsc stent ((b)(4); x2=15.58: p<0.001).The incident rate of adverse events for one year was almost same in the two groups.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7513819
MDR Text Key108244314
Report Number2134265-2018-03979
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial
Report Date 04/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK776
Was Device Available for Evaluation? No
Date Manufacturer Received04/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-